Webcast: Manipulation of IVF Outcome Reporting to SART

The status of public reporting of clinical outcomes in assisted reproductive technology

Center For Human Reproduction: Dr. Vitaly A. Kushnir, leading fertility specialist in US

Presented by Vitaly A Kushnir, MD,

Physician, Associate Scientist & Director of Continuing Medical Education

New York, NY, USA

Tuesday, July 16, 2013
12:30pm – 1:00pm

The U.S. government requires all IVF centers to report their IVF cycle outcomes to Centers for Disease Control and Prevention (CDC). A majority of IVF centers also report this data to the Society for Assisted Reproductive Technologies (SART). Despite CDC and SART’s warning that published IVF pregnancy rates cannot be a reliable basis for identifying a successful IVF center for a given patient due to patient selection bias, the data published by CDC and SART have become a default tool to do just that for many patients.

A recent publication in Fertility & Sterility uncovered a disturbing trend against this backdrop: a small minority of IVF centers (13 out of 341 centers analyzed) exclude a disproportionately large number of IVF cycle outcomes from reporting, artificially inflating their IVF pregnancy rates. By the year 2010, these 13 IVF centers accounted for more than 50% of all IVF cycles excluded from SART/CDC reporting, and partially as a result, these centers’ U.S. market share has expanded by nearly 20% between 2005 and 2010.

This live webcast, presented by Vitaly A Kushnir, MD, the lead author of the study, provides an overview of the CDC/SART outcome reporting system, discusses the findings of the study, and gives patients points to consider when choosing an IVF center that best suits their needs.

Visit our webcast index for additional information on infertility topics.

Norbert Gleicher, MD, leads CHR’s clinical and research efforts as Medical Director and Chief Scientist. A world-renowned reproductive endocrinologist, Dr. Gleicher has published hundreds of peer-reviewed papers and lectured globally while keeping an active clinical career focused on ovarian aging, immunological issues and other difficult cases of infertility.